Loading clinical trials...
Loading clinical trials...
Predictive Assays in Cervix Cancer: Assessment of Hypoxia, Interstitial Fluid Pressure, and GSH Levels
The aim of this study is to measure the oxygen content and interstitial fluid pressure in cervix cancer patients. Tumour oxygen content and internal pressure of tumours may be an important factor that influences the effectiveness of radiotherapy and other treatments.
Age
18 - No limit years
Sex
FEMALE
Healthy Volunteers
No
Princess Margaret Hospital
Toronto, Ontario, Canada
Start Date
December 1, 1995
Primary Completion Date
December 1, 2027
Completion Date
December 1, 2027
Last Updated
March 6, 2026
346
ACTUAL participants
Pre-treatment tumour oxygen measurements (under anesthesia)
PROCEDURE
Lead Sponsor
University Health Network, Toronto
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions